Cargando…

The Expression of the Endocannabinoid Receptors CB2 and GPR55 Is Highly Increased during the Progression of Alzheimer’s Disease in App(NL-G-F) Knock-In Mice

SIMPLE SUMMARY: Alzheimer’s disease (AD) is a complex, multifactorial disease where numerous components, such as environment, lifestyle, comorbidities, and genetic predisposition, contribute to triggering the onset of the disease. Several neurobiological brain alterations have been reported during A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Medina-Vera, Dina, Zhao, Hongjing, Bereczki, Erika, Rosell-Valle, Cristina, Shimozawa, Makoto, Chen, Gefei, de Fonseca, Fernando Rodríguez, Nilsson, Per, Tambaro, Simone
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295339/ https://www.ncbi.nlm.nih.gov/pubmed/37372090 http://dx.doi.org/10.3390/biology12060805

Ejemplares similares

Translational potential of synaptic alterations in Alzheimer’s disease patients and amyloid precursor protein knock-in mice
por: Medina-Vera, Dina, et al.
Publicado: (2023)

Autophagy Impairment in App Knock-in Alzheimer’s Model Mice
por: Jiang, Richeng, et al.
Publicado: (2022)

Feasibility and therapeutical potential of local intracerebral encapsulated cell biodelivery of BDNF to App(NL−G−F) knock-in Alzheimer mice
por: Tambaro, Simone, et al.
Publicado: (2023)

Increased Insoluble Amyloid-β Induces Negligible Cognitive Deficits in Old App(NL/NL) Knock-In Mice
por: Salas, Isabel H., et al.
Publicado: (2018)

Age-Dependent Behavioral and Metabolic Assessment of App(NL−G−F/NL−G−F) Knock-in (KI) Mice
por: Wang, Shanshan, et al.
Publicado: (2022)

The two faces of synaptic failure in App(NL-G-F) knock-in mice
por: Latif-Hernandez, Amira, et al.
Publicado: (2020)

Mitochondrial Alterations in Neurons Derived from the Murine App(NL-F) Knock-In Model of Alzheimer’s Disease
por: Dentoni, Giacomo, et al.
Publicado: (2022)

Some Prospective Alternatives for Treating Pain: The Endocannabinoid System and Its Putative Receptors GPR18 and GPR55
por: Guerrero-Alba, Raquel, et al.
Publicado: (2019)

CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation
por: Zhou, Juan, et al.
Publicado: (2016)

Functional characterization of the novel cannabinoid receptor GPR55 and its modulation by CB(1 )and CB(2 )receptors
por: Balenga, Nariman, et al.
Publicado: (2008)

Spatial reversal learning defect coincides with hypersynchronous telencephalic BOLD functional connectivity in APP(NL-F/NL-F) knock-in mice
por: Shah, Disha, et al.
Publicado: (2018)

A high‐fat diet exacerbates the Alzheimer's disease pathology in the hippocampus of the App (NL−F/NL−F) knock‐in mouse model
por: Mazzei, Guianfranco, et al.
Publicado: (2021)

Genetically-targeted photorelease of endocannabinoids enables optical control of GPR55 in pancreatic β-cells
por: Tobias, Janelle M., et al.
Publicado: (2021)

Characterization of different G protein coupling properties of CB(1 )and CB(2 )cannabinoid receptors and GPR55 receptor using BRET
por: Gyombolai, Pál, et al.
Publicado: (2009)

Increase in Tau Pathology in P290S Mapt Knock-In Mice Crossed with App(NL-G-F) Mice
por: Huang, Melissa, et al.
Publicado: (2022)

Lysophosphatidylinositol Promotes Chemotaxis and Cytokine Synthesis in Mast Cells with Differential Participation of GPR55 and CB2 Receptors
por: Martínez-Aguilar, Lizbeth Magnolia, et al.
Publicado: (2023)

Expression of cannabinoid (CB1 and CB2) and cannabinoid-related receptors (TRPV1, GPR55, and PPARα) in the synovial membrane of the horse metacarpophalangeal joint
por: Zamith Cunha, Rodrigo, et al.
Publicado: (2023)

An App knock-in rat model for Alzheimer’s disease exhibiting Aβ and tau pathologies, neuronal death and cognitive impairments
por: Pang, Keliang, et al.
Publicado: (2021)

Structural basis for activation of CB1 by an endocannabinoid analog
por: Krishna Kumar, Kaavya, et al.
Publicado: (2023)

The therapeutic potential of orphan GPCRs, GPR35 and GPR55
por: Shore, Derek M., et al.
Publicado: (2015)

Ginseng Gintonin Contains Ligands for GPR40 and GPR55
por: Cho, Yeon-Jin, et al.
Publicado: (2020)

Retinal Thickness Changes Over Time in a Murine AD Model APP(NL-F/NL-F)
por: Salobrar-García, Elena, et al.
Publicado: (2021)

GPR55: signaling pathways and functions
por: Balenga, Nariman, et al.
Publicado: (2009)

Endocannabinoid engagement of CB(2) regulates RSV-induced immunity
por: Kaplan, Barbara L. F.
Publicado: (2018)

SAK3 Administration Improves Spine Abnormalities and Cognitive Deficits in App(NL-G-F/NL-G-F) Knock-in Mice by Increasing Proteasome Activity through CaMKII/Rpt6 Signaling
por: Izumi, Hisanao, et al.
Publicado: (2020)

Cerebral Aβ deposition precedes reduced cerebrospinal fluid and serum Aβ42/Aβ40 ratios in the App(NL−F/NL−F) knock-in mouse model of Alzheimer’s disease
por: Andersson, Emelie, et al.
Publicado: (2023)

Early memory deficits and extensive brain network disorganization in the App(NL-F)/MAPT double knock-in mouse model of familial Alzheimer’s disease
por: Borcuk, Christopher, et al.
Publicado: (2022)

Integrated analysis of behavioral, epigenetic, and gut microbiome analyses in App(NL-G-F), App(NL-F), and wild type mice
por: Kundu, Payel, et al.
Publicado: (2021)

GPR55 and GPR119 Receptors Contribute to the Processing of Neuropathic Pain in Rats
por: Zúñiga-Romero, Ángel, et al.
Publicado: (2022)

GPR119 and GPR55 as Receptors for Fatty Acid Ethanolamides, Oleoylethanolamide and Palmitoylethanolamide
por: Im, Dong-Soon
Publicado: (2021)

Angiotensin II-Induced Cardiac Effects Are Modulated by Endocannabinoid-Mediated CB(1) Receptor Activation
por: Miklós, Zsuzsanna, et al.
Publicado: (2021)

Impaired spike-gamma coupling of area CA3 fast-spiking interneurons as the earliest functional impairment in the App(NL-G-F) mouse model of Alzheimer’s disease
por: Arroyo-García, Luis Enrique, et al.
Publicado: (2021)

Pathological and neurophysiological outcomes of seeding human-derived tau pathology in the APP-KI NL-G-F and NL-NL mouse models of Alzheimer’s Disease
por: Tok, S., et al.
Publicado: (2022)

Pharmacological characterization of the endocannabinoid sensor GRAB(eCB2.0)
por: Singh, Simar, et al.
Publicado: (2023)

Imbalance of Endocannabinoid/Lysophosphatidylinositol Receptors Marks the Severity of Alzheimer’s Disease in a Preclinical Model: A Therapeutic Opportunity
por: Medina-Vera, Dina, et al.
Publicado: (2020)

Potential Metabolic and Behavioural Roles of the Putative Endo- cannabinoid Receptors GPR18, GPR55 and GPR119 in Feeding
por: Ramírez-Orozco, Ricardo E., et al.
Publicado: (2019)

Intranasal delivery of pro-resolving lipid mediators rescues memory and gamma oscillation impairment in App(NL-G-F/NL-G-F) mice
por: Emre, Ceren, et al.
Publicado: (2022)

Identification of G protein-coupled receptor 55 (GPR55) as a target of curcumin
por: Harada, Naoki, et al.
Publicado: (2022)

A potential role for GPR55 in gastrointestinal functions
por: Schicho, Rudolf, et al.
Publicado: (2012)

Advances in the Physiology of GPR55 in the Central Nervous System
por: Marichal-Cancinoa, Bruno A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8tcdmpge3773ulmhbu8ocimeno